Acadia Pharmaceuticals Inc (ACAD)
Other Income/Expenses (Net)
$35.00M
TTM · Period ending: · USD
ACAD Other Income/Expenses (Net)
Latest reported$35.00Mperiod ending
Latest reported$35.00Mperiod ending
ACAD TTM Other Income/Expenses (Net) ($17.43M → $35.00M)
TTM Other Income/Expenses (Net)
High-resolution chart · PNG
ACAD other income/expenses (net) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Other Income/Expenses (Net) (USD) |
|---|---|
| 35,001,000 | |
| 34,201,000 | |
| 34,093,000 | |
| 32,747,000 | |
| 31,070,000 | |
| 29,978,000 | |
| 27,281,000 | |
| 24,458,000 | |
| 22,929,000 | |
| 19,490,000 | |
| 22,343,000 | |
| 22,757,000 | |
| 21,575,000 | |
| 18,352,000 | |
| 10,152,000 | |
| 6,731,000 | |
| 2,792,000 | |
| 3,020,000 | |
| 2,920,000 | |
| 1,987,000 | |
| 2,515,000 | |
| 4,466,000 | |
| 5,613,000 | |
| 8,557,000 | |
| 10,696,000 | |
| 10,949,000 | |
| 12,162,000 | |
| 10,196,000 | |
| 6,526,000 | |
| 5,043,000 | |
| 3,508,000 | |
| 2,818,000 | |
| 4,372,000 | |
| 4,333,000 | |
| 4,126,000 | |
| 3,895,000 | |
| 3,618,000 | |
| 3,226,000 | |
| 2,763,000 | |
| 1,998,000 | |
| 1,304,000 | |
| 822,000 | |
| 499,000 | |
| 576,000 | |
| 692,000 | |
| 801,000 | |
| 754,000 | |
| 681,000 | |
| 589,000 | |
| 437,000 | |
| 348,000 | |
| -13,797,000 | |
| -13,908,000 | |
| -13,974,000 | |
| -14,002,000 | |
| -17,423,000 | |
| -17,411,000 | |
| -17,393,000 | |
| -17,378,000 | |
| -13,917,000 | |
| -13,919,000 | |
| -13,939,000 | |
| -13,958,000 | |
| -36,408,000 | |
| -36,377,000 | |
| -36,292,000 | |
| -36,134,000 | |
| -33,347,000 | |
| -32,918,000 | |
| -32,255,000 | |
| -30,361,000 | |
| -34,393,000 | |
| -33,020,000 | |
| -31,926,000 | |
| -33,088,000 | |
| -26,900,000 | |
| -16,209,000 | |
| -5,195,000 | |
| 4,006,000 | |
| 12,067,600 | |
| 12,341,600 | |
| 456,277,600 | |
| 657,177,600 | |
| 840,173,200 | |
| 935,360,200 | |
| 484,445,500 | |
| 273,445,500 | |
| 133,159,100 | |
| 23,314,500 | |
| 17,429,200 | |
| 17,429,200 |